Being aware that AMPs other than DCD play a role in HS etio-pathogenesis, restoring physiological levels of DCD in HS patients could be very interesting ansinced this molecule could constitute a novel target for personalised therapeutic approach. Here, DCD is linked to histiocytic sarcoma.